AC
Aisling Capital Portfolio holdings
AUM
$45.3M
This Quarter Return
+4.87%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$345M
AUM Growth
+$345M
(+140%)
Cap. Flow
+$199M
Cap. Flow
% of AUM
57.63%
Top 10 Holdings %
Top 10 Hldgs %
93.43%
Holding
14
New
9
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$55.9M |
| 2 |
ASXC
Asensus Surgical, Inc.
ASXC
|
$42M |
| 3 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$39.5M |
| 4 |
CEMP
Cempra, Inc.
CEMP
|
$35.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$32.5M |
Top Sells
| 1 |
IQVIA
IQV
|
$58.6M |
| 2 |
DRTX
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
|
$17M |
Sector Composition
| 1 | Healthcare | 75.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARAV
1
DELISTED
Aravive, Inc. Common Stock
ARAV
| $55.9M | 16.17% | +1,994,568 | New | +$55.9M |
|
|
ASXC
2
DELISTED
Asensus Surgical, Inc.
ASXC
| $42M | 12.14% | +8,335,819 | New | +$42M |
|
|
ZLTQ
3
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $39.5M | 11.41% | +2,597,742 | New | +$39.5M |
|
|
CEMP
4
DELISTED
Cempra, Inc.
CEMP
| $35.3M | 10.21% | +3,293,060 | New | +$35.3M |
|
|
DRTX
5
DELISTED
DURATA THERAPEUTICS INC COM STK (DE)
DRTX
| $34.6M | 9.99% | 2,030,175 -1,000,000 | -33% | -$17M |
|
|
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
| $33.4M | 9.66% | 1,522,943 +300,000 | +25% | +$6.58M |
|
|
7
Esperion Therapeutics
ESPR
$448M
| $32.5M | 9.41% | +2,054,594 | New | +$32.5M |
|
|
AGRX
8
DELISTED
Agile Therapeutics, Inc
AGRX
| $18.9M | 5.47% | +2,171,831 | New | +$18.9M |
|
|
PTX
9
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $18.1M | 5.22% | +2,010,000 | New | +$18.1M |
|
|
SRNE
10
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $11.9M | 3.44% | 1,763,500 +1,142,800 | +184% | +$7.71M |
|
|
AMBI
11
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $11.4M | 3.3% | +1,650,156 | New | +$11.4M |
|
|
EVAR
12
DELISTED
Lombard Medical, Inc.
EVAR
| $6.38M | 1.84% | +886,363 | New | +$6.38M |
|
13
MEI Pharma
MEIP
$160M
| $4.88M | 1.41% | 770,000 | – | – |
|
|
14
IQVIA
IQV
$32.4B
| – | – | -1,153,773 | Closed | -$58.6M |
|